Abstract
Rationale
Working memory performance may be improved or decreased by amphetamine, depending on baseline working memory capacity and amphetamine dosage. This variable effect suggests an optimal range of monaminergic activity for working memory, either below or above which it is compromised. We directly tested this possibility with human participants by varying amphetamine dosage and measuring the efficiency of cortical processing in brain regions associated with working memory.
Objectives
The modulation of cortical processing in a verbal working memory network by dextroamphetamine (d-amph) was examined using BOLD functional magnetic resonance imaging (fMRI) with healthy participants. The goal of the study was to test the hypothesis of an inverted U-shaped relationship between d-amph dose and processing efficiency of a verbal working memory system.
Methods
d-amph dosage was increased cumulatively every 2 h across four scanning sessions collected in a single day. The primary measure used for analyses in this study was the extent of activation in brain regions empirically defined as a working memory network.
Results
An inverted U-shaped relationship was observed between the amount of d-amph administered and working memory processing efficiency. This relationship was specific to brain areas functionally defined as working memory regions and to the encoding/maintenance phase (as opposed to the response phase) of the task.
Conclusion
The results are consistent with the hypothesis that the neurochemical effects of amphetamine modulate the efficiency of a verbal working memory system. The effect of amphetamine on working memory in healthy individuals may provide insight regarding the working memory deficits seen in schizophrenia, given the overlap between neurochemical systems affected by amphetamine, and those disordered in schizophrenia.
Similar content being viewed by others
Notes
We based these hypotheses both on previous research showing that a low dose of amphetamine can improve working memory performance, as well as on pilot work from our own lab that showed a 20-mg dose of amphetamine greatly hindered working memory performance and exacerbated cortical processing efficiency on a similar task. We want to emphasize that these predictions were specific to the particular task employed in this experiment and acknowledge that a given dose of amphetamine will have differential effects depending on the individual and the specific task employed.
For example, Uftring et al. (2001) found that a 20-mg dose of amphetamine increased the extent of activation in task-related cortical regions, but did not have any effect on reaction time or accuracy. To achieve the same level of behavioural performance, more cortex was recruited during the task—a reduction in cortical processing efficiency.
We would like to clarify that the use of the terms “low dose”, “medium dose”, and “high dose” is relative to the dosage levels used in the present study. A 12.5-mg dose of d-amph is not in fact a particularly high dose (25 mg would typically be considered a high dose), but it was the highest dose employed here.
We must note that these data are an average of both men and women. As one reviewer pointed out, men and women may differ in their response to amphetamine. To ensure that no such differences were present in this study, we conducted an ANOVA for the amphetamine group with sex as a between-subjects factor, and dose and load as within-subjects factors, using the voxel counts obtained from the a-priori mask as the dependent measure. There were no significant main or interaction effects of sex (all ps>0.05), indicating that in the present study, amphetamine affected brain activity in a similar manner for both men and women.
A similar data pattern was obtained for the peak response amplitude estimates for these focal regions of interest. That is, a U-shaped relationship between BOLD response amplitude and amphetamine dose was present only for the encoding/maintenance phase of the task, and only in the dorsolateral prefrontal cortex. The quadratic trend for the response amplitude data, however, did not quite reach significance, t (11)=1.44, p=0.08. Where as voxel counts and response amplitude estimates are certainly not independent, this result highlights the fact that the two measures are dissociable. Given that the present research question centers on cortical efficiency, we felt activation extent rather than peak amplitude was the appropriate measure.
References
Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J (1997) The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci 9:1–17
Arnsten AFT (1998) Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2:436–447
Arnsten AFT (2004) Adrenergic targets for the treatment of cognitive deficits in schizophrenia. Psychopharmacology 174:25–31
Arnsten AFT, Goldman-Rakic PS (1998) Noise stress impairs prefrontal cortical function in monkeys: evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 55:362–368
Arnsten AFT, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116:143–151
Aultman JM, Moghaddam B (2001) Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology 153:353–364
Baranski JV, Pigeau RA (1997) Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. J Sleep Res 6(2):84–91
Brozoski, TJ, Brown, RM, Rosvold, HE, Goldman, PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205 (4409):929–932
Bubser M, Schmidt WJ (1990) 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res 37:157–168
Cai JX, Arnsten AFT (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183–187
Cairo TA, Liddle PF, Woodward TS, Ngan ETC (2004) The influence of working memory load on phase specific patterns of cortical activity. Cogn Brain Res 21:377–387
Castner SA, Goldman-Rakic PS (2004) Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. J Neurosci 24(6):1446–1450
Castner SA, Williams GV, Goldman-Rakic PS (2000) Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287:2020–2022
Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE (1991) The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11(7):1907–1917
Devous MD Sr, Trivedi MH, Rush AJ (2001) Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. J Nucl Med 42(4):535–542
Egan M, Goldberg T, Kolachana B, Callicott J, Mazzanti C, Straub R, Goldman D, Weinberger D (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917–6922
Elliott R, Sahakian BJ, Matthews K, Bannerja A, Rimmer J, Robbins TW (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131:196–203
Ernst M, Zametkin AJ, Matochik J, Schmidt M, Jons PH, Liebenauer LL, Hardy KK, Cohen RM (1997) Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 17(6):391–401
Friedman JI, Temporini H, Davis KL (1999) Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol Psychiatry 45:1–16
Friston KJ, Holmes AP, Worsley KJ, Poline JB, Grasby PJ, Frith CD, Frackowiak RSJ (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189–210
Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54:159–165
Goldberg TE, Patterson KJ, Taqqu Y, Wilder K (1998) Capacity limitations in short-term memory in schizophrenia. Psychol Med 28:665–673
Goldman-Rakic PS (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry 6:348–357
Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenheiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48:627–640
Kimberg DY, D'Esposito M, Farah MJ (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8(16):3581–3585
Landro NI, Stiles TC, Sletvold H (2001) Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 14:233–240
Laruelle M, Abi-Dargham A (1999) Dopamine as the wind of the psychotic: new evidence from brain imaging studies. J Psychopharmacol 13(4):358–371
Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 93(17):9235–9240
Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia. From pathophysiology to treatment. Ann N Y Acad Sci 1003:138–158
Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A (2002) Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 27(6):1027–1035
Magill RA, Waters WF, Bray GA, Volaufova J, Smith SR, Lieberman HR, McNevin N, Ryan DH (2003) Effects of tyrosine, phentermine, caffeine d-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr Neurosci 6(4):237–246
Mattay VS, Berman KF, Ostrem JL, Esposito G, Van Horn JD, Bigelow LB, Weinberger DR (1996) Dextroamphetamine enhances “neural network-specific” physiological signals: a positron-emission tomography rCBF study. J Neurosci 16(15):4816–4822
Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 13(3):433–446
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100(10):6186–6191
Mendrek A, Laurens KR, Kiehl KA, Ngan ETC, Stip E, Liddle PF (2004) Changes in distributed neural circuitry function in first episode schizophrenic patients during test-retest of a working memory task. Br J Psychiatry 185:205–214
Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5(3):267–271
Muller U, Yves von Cramon D, Pollman S (1998) D1 versus D2 receptor modulation of visuospatial working memory in humans. J Neurosci 18:2720–2728
Pelosi L, Slade T, Blumhardt LD, Sharma VK (2000) Working memory dysfunction in major depression: an event-related potential study. Clin Neurophysiol 111:1531–1543
Phillips AG, Ahn S, Floresco SB (2004) Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 24(2):547–553
Robbins TW (2000) Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133:165–183
Romanides AJ, Duffy P, Kalivas PW (1999) Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience 92:97–106
Sawaguchi T, Goldman-Rakic PS (1991) Dopamine D1 receptors in prefrontal cortex: involvement in working memory. Science 251:947–950
Schmidt ME, Ernst M, Matochik JA, Maisog JM, Pan BS, Zametkin AJ, Potter WZ (1996) Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions. J Nucl Med 37(7):1142–1149
Seamans JK, Floresco SB, Phillips AG (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 18:1613–1621
Servan-Schreiber D, Carter CS, Bruno RM, Cohen JD (1998) Dopamine and the mechanisms of cognition: part II. d-Amphetamine effects in human subjects performing a selective attention task. Biol Psychiatry 43:723–729
Shappell SA, Neri DF, DeJohn CA (1992) Simulated sustained flight operations and performance. Part 2: effects of dextro-amphetamine. Mil Psychol 4(4):267–287
Soares JC, Innis RB (1999) Neurochemical brain imaging investigations of schizophrenia. Biol Psychiatry 46:600–615
Uftring SJ, Wachtel SR, Chu D, McCandless C, Levin DN, de Wit H (2001) An fMRI study of the effect of amphetamine on brain activity. Neuropsychopharmacology 25:925–935
Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572–575
Wolkin A, Angrist B, Wolf A, Brodie J, Wolkin B, Jaeger J, Cancro R, Rotrosen J (1987) Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology 92(2):241–246
Zahrt J, Taylor JR, Mathew RG, Arnsten AFT (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs working memory performance. J Neurosci 17:8528–8535
Acknowledgements
The authors would like to thank the Michael Smith Foundation for Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Dr. Norma Calder Schizophrenia Foundation for their support of this research.
All participants in this experiment provided informed consent prior to their participation in the study. This research was conducted with the approval of the University of British Columbia Clinical Research Ethics Board and in accordance with the current laws of Canada.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tipper, C.M., Cairo, T.A., Woodward, T.S. et al. Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation. Psychopharmacology 180, 634–643 (2005). https://doi.org/10.1007/s00213-005-0025-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-005-0025-4